OmanDocSign in

Curriculum · Metabolic and Endocrine and Diabetes Mellitus

Growth hormone therapy and slipped capital femoral epiphysis

What it is

Slipped capital femoral epiphysis (SCFE) is displacement of the femoral head epiphysis postero-inferiorly, and it is the most common hip disorder in adolescents. Treatment with growth hormone (GH) carries the risk of an increased incidence of slipped capital femoral epiphysis, especially in rapidly growing adolescents. An adolescent with idiopathic growth hormone deficiency who is started on biosynthetic recombinant DNA-derived GH is therefore at high risk for it.

Causes and risk

The age band given for SCFE is 8-15 years, and elsewhere 10-15 years. It is more common in obese children, and although it has in the past been more common in boys than in girls, that prevalence is changing due to the rise in obesity. It is rarely associated with trauma, overuse, or prior illness. Growth hormone treatment is an added risk, especially during rapid growth.

How it presents

SCFE should be suspected in an adolescent who has unexplained pain in the hip, groin, thigh, or knee, and the pain may be felt in the medial thigh. A new limp together with pain in the groin, hip, thigh, or knee is what should prompt radiographs. On examination the most indicative sign is limited internal rotation of the involved hip, which is also described as loss of internal rotation of the leg in flexion.

How it is diagnosed

Bilateral radiographs of the hips, including frog-leg lateral views, should be obtained in any adolescent who presents with a new limp and pain in the groin, hip, thigh, or knee. AP and lateral views, typically the frog-leg view, are diagnostic. Conditions to distinguish from SCFE are adductor muscle strain, which is very uncommon in adolescents, Legg-Calvé-Perthes disease and transient synovitis, which are more common in children under age 10 and give a similar picture of hip pain and a limp, and apophysitis of the anterior superior iliac spine, which is common in adolescents but is caused by overuse and is mostly seen in runners, dancers, and ice hockey and soccer players ages 14-18.